CN106727733B - 一种鲜冬虫夏草抗肿瘤化疗的联合药物及其应用 - Google Patents
一种鲜冬虫夏草抗肿瘤化疗的联合药物及其应用 Download PDFInfo
- Publication number
- CN106727733B CN106727733B CN201611222091.9A CN201611222091A CN106727733B CN 106727733 B CN106727733 B CN 106727733B CN 201611222091 A CN201611222091 A CN 201611222091A CN 106727733 B CN106727733 B CN 106727733B
- Authority
- CN
- China
- Prior art keywords
- cordyceps sinensis
- fresh cordyceps
- extract
- fresh
- cisplatin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001248610 Ophiocordyceps sinensis Species 0.000 title claims abstract description 73
- 238000002512 chemotherapy Methods 0.000 title claims abstract description 22
- 239000003814 drug Substances 0.000 title claims abstract description 20
- 230000000259 anti-tumor effect Effects 0.000 title abstract description 12
- 239000000284 extract Substances 0.000 claims abstract description 50
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims abstract description 48
- 229960004316 cisplatin Drugs 0.000 claims abstract description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 33
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 32
- 238000000605 extraction Methods 0.000 claims abstract description 23
- 208000020816 lung neoplasm Diseases 0.000 claims abstract description 17
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims abstract description 15
- 201000005202 lung cancer Diseases 0.000 claims abstract description 15
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 14
- 210000005228 liver tissue Anatomy 0.000 claims abstract description 6
- 210000005084 renal tissue Anatomy 0.000 claims abstract description 6
- 239000006228 supernatant Substances 0.000 claims description 19
- 238000007710 freezing Methods 0.000 claims description 12
- 230000008014 freezing Effects 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 9
- 238000004108 freeze drying Methods 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 5
- 230000014759 maintenance of location Effects 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 238000010257 thawing Methods 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000010008 shearing Methods 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 241000190633 Cordyceps Species 0.000 abstract description 28
- 230000000694 effects Effects 0.000 abstract description 17
- 229940079593 drug Drugs 0.000 abstract description 10
- 239000002246 antineoplastic agent Substances 0.000 abstract description 8
- 229940044683 chemotherapy drug Drugs 0.000 abstract description 8
- 238000011160 research Methods 0.000 abstract description 8
- 230000002195 synergetic effect Effects 0.000 abstract description 6
- 230000001681 protective effect Effects 0.000 abstract description 5
- 230000000451 tissue damage Effects 0.000 abstract description 5
- 231100000827 tissue damage Toxicity 0.000 abstract description 5
- 238000009098 adjuvant therapy Methods 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 230000001603 reducing effect Effects 0.000 abstract description 3
- 239000002904 solvent Substances 0.000 abstract description 3
- 230000012010 growth Effects 0.000 abstract description 2
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 22
- 230000001276 controlling effect Effects 0.000 description 11
- 239000008367 deionised water Substances 0.000 description 11
- 229910021641 deionized water Inorganic materials 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 10
- 230000005764 inhibitory process Effects 0.000 description 8
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 7
- 239000007928 intraperitoneal injection Substances 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 229910052697 platinum Inorganic materials 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 229940109239 creatinine Drugs 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 101000578412 Amyda cartilaginea Lysozyme C Proteins 0.000 description 3
- 102100027710 Astacin-like metalloendopeptidase Human genes 0.000 description 3
- 101000936739 Homo sapiens Astacin-like metalloendopeptidase Proteins 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010062016 Immunosuppression Diseases 0.000 description 2
- 208000006552 Lewis Lung Carcinoma Diseases 0.000 description 2
- 206010067125 Liver injury Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010061481 Renal injury Diseases 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 208000037806 kidney injury Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 208000037841 lung tumor Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- 241001480006 Clavicipitaceae Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 241000130660 Hepialidae Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010027406 Mesothelioma Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010029155 Nephropathy toxic Diseases 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 206010033109 Ototoxicity Diseases 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 206010048899 Radiation oesophagitis Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000001099 axilla Anatomy 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 229940000425 combination drug Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 238000013400 design of experiment Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 201000010536 head and neck cancer Diseases 0.000 description 1
- 208000014829 head and neck neoplasm Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 230000007694 nephrotoxicity Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- 231100000262 ototoxicity Toxicity 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000010837 poor prognosis Methods 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 208000006934 radiodermatitis Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000015608 reproductive system cancer Diseases 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- GBABOYUKABKIAF-GHYRFKGUSA-N vinorelbine Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-GHYRFKGUSA-N 0.000 description 1
- 229960002066 vinorelbine Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
组别 | 剂量/mg·kg<sup>-1</sup> | 肿瘤重量(g) | 抑瘤率(%) |
A.模型给药组 | - | 3.27±0.42<sup>**</sup> | - |
B.顺铂给药组 | 2 | 1.77±0.22 | 45.9 |
C.(实施例3+顺铂)给药组 | 200+2 | 2.09±0.43 | 36.1 |
D.(实施例3+顺铂)给药组 | 800+2 | 1.58±0.26 | 45.7 |
E.(实施例1+顺铂)给药组 | 200+2 | 1.19±0.20* | 63.6 |
F.(实施例1+顺铂)给药组 | 800+2 | 1.08±0.28* | 67.0 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611222091.9A CN106727733B (zh) | 2016-12-27 | 2016-12-27 | 一种鲜冬虫夏草抗肿瘤化疗的联合药物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611222091.9A CN106727733B (zh) | 2016-12-27 | 2016-12-27 | 一种鲜冬虫夏草抗肿瘤化疗的联合药物及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106727733A CN106727733A (zh) | 2017-05-31 |
CN106727733B true CN106727733B (zh) | 2020-03-24 |
Family
ID=58925842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611222091.9A Active CN106727733B (zh) | 2016-12-27 | 2016-12-27 | 一种鲜冬虫夏草抗肿瘤化疗的联合药物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106727733B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526127A (zh) * | 2012-03-28 | 2012-07-04 | 辽宁大学 | 蛹虫草中有效成分的闪式提取方法 |
CN103214533A (zh) * | 2013-04-19 | 2013-07-24 | 湖南农业大学 | 一种膜分离技术连续制备虫草素和虫草多糖的方法 |
-
2016
- 2016-12-27 CN CN201611222091.9A patent/CN106727733B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526127A (zh) * | 2012-03-28 | 2012-07-04 | 辽宁大学 | 蛹虫草中有效成分的闪式提取方法 |
CN103214533A (zh) * | 2013-04-19 | 2013-07-24 | 湖南农业大学 | 一种膜分离技术连续制备虫草素和虫草多糖的方法 |
Non-Patent Citations (1)
Title |
---|
冬虫夏草合用顺铂诱导非小细胞肺癌凋亡的研究;徐晋等;《南京中医药大学学报》;20081130;第24卷(第06期);第398-400页 * |
Also Published As
Publication number | Publication date |
---|---|
CN106727733A (zh) | 2017-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5135745A (en) | Extracts of nerium species, methods of preparation, and use therefore | |
CN102153668B (zh) | 一种抗癌的黄绿蜜环菌多糖及提取工艺 | |
TW201618801A (zh) | 用於輔助化療藥物之醫藥組合物及其用途 | |
WO2007007993A1 (en) | Pharmaceutical composition for the prevention and treatment of liver disease comprising a lonicera caerulea l. var. edulis extract | |
CN101249259A (zh) | 一种高含量、高活性口服云芝糖肽及其制备方法和应用 | |
CN112057546A (zh) | 一种蜂胶灵芝孢子粉组合物及其制备方法和应用 | |
Sun | The role of Chinese medicine in clinical oncology | |
CN115120689A (zh) | 欣力康复方制剂在制备药物中的应用 | |
CN105664140A (zh) | 一种糖肽组合物及其制备方法和用途 | |
CN106727733B (zh) | 一种鲜冬虫夏草抗肿瘤化疗的联合药物及其应用 | |
CN102078600B (zh) | 抗癌复方灵芝组合物、其用途和包含其的药物组合物 | |
CN108553504A (zh) | 参芪粉及其制备方法 | |
US20190070246A1 (en) | Traditional chinese medicine composition and use thereof | |
CN108939043A (zh) | 一种鲨鱼软骨糖蛋白及其抗癌用途 | |
CN104825783B (zh) | 具有抗肿瘤活性的中药组合物及其制备方法和应用 | |
CN110279780B (zh) | 一种具有抑制肿瘤细胞生长的中药溶液 | |
CN113134034A (zh) | 一种中药组合物、应用及中药制剂 | |
TW201808316A (zh) | 牛樟段木栽培牛樟芝子實體及固態培養菌絲體水及乙醇萃取物之組合物應用於抗癌藥輔助劑 | |
CN102423384B (zh) | 一种治疗肺癌的中药制剂及其制备方法 | |
CN106110312A (zh) | 乌司他丁在制备治疗胆囊癌药物中的用途 | |
CN108635560A (zh) | 一种治疗淋巴瘤的中药及其制备方法 | |
CN104840747B (zh) | 具有抗甲状腺癌活性的中药组合物及其制备方法和应用 | |
CN110025643B (zh) | 一种抗癌活性复方物及其制备方法与应用 | |
CN107929344B (zh) | 一种用于预防及治疗喉癌的紫草复方组合物 | |
CN112138066B (zh) | 龙葵或龙葵提取物在增加抗生素或抗肿瘤药物敏感性中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1234653 Country of ref document: HK |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200525 Address after: Room 302, building 32, No. 368, Zhenan Middle Road, Chang'an Town, Dongguan City, Guangdong Province Co-patentee after: YICHANG SHANCHENGSHUIDU CORDYCEPS Co.,Ltd. Patentee after: Dongguan dongyangguang Cordyceps research and Development Co.,Ltd. Address before: 523808 Guangdong city of Dongguan province Hubei Songshan Industrial Park Industrial Road No. 1 Co-patentee before: YICHANG SHANCHENGSHUIDU CORDYCEPS Co.,Ltd. Patentee before: SUNSHINE LAKE PHARMA Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A combined drug of fresh Cordyceps sinensis for anti-tumor chemotherapy and its application Effective date of registration: 20210923 Granted publication date: 20200324 Pledgee: Shenzhen branch of China Import and Export Bank Pledgor: Dongguan dongyangguang Cordyceps research and Development Co.,Ltd.|YICHANG SHANCHENGSHUIDU CORDYCEPS Co.,Ltd. Registration number: Y2021980009771 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220926 Granted publication date: 20200324 Pledgee: Shenzhen branch of China Import and Export Bank Pledgor: Dongguan dongyangguang Cordyceps research and Development Co.,Ltd.|YICHANG SHANCHENGSHUIDU CORDYCEPS Co.,Ltd. Registration number: Y2021980009771 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A combination of fresh Cordyceps sinensis with anti-tumor chemotherapy and its application Effective date of registration: 20220929 Granted publication date: 20200324 Pledgee: Shenzhen branch of China Import and Export Bank Pledgor: Dongguan dongyangguang Cordyceps research and Development Co.,Ltd.|YICHANG SHANCHENGSHUIDU CORDYCEPS Co.,Ltd. Registration number: Y2022980017022 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230920 Granted publication date: 20200324 Pledgee: Shenzhen branch of China Import and Export Bank Pledgor: YICHANG SHANCHENGSHUIDU CORDYCEPS Co.,Ltd.|Dongguan dongyangguang Cordyceps research and Development Co.,Ltd. Registration number: Y2022980017022 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A combination drug of fresh Cordyceps sinensis for anti-tumor chemotherapy and its application Effective date of registration: 20230927 Granted publication date: 20200324 Pledgee: Shenzhen branch of China Import and Export Bank Pledgor: Dongguan dongyangguang Cordyceps research and Development Co.,Ltd.|YICHANG SHANCHENGSHUIDU CORDYCEPS Co.,Ltd. Registration number: Y2023980059372 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |